Developer docs
API playgroundTry for free, no card

Search company profiles

EKF Diagnostics

Full company profile

uuid000vfls

Namestring
EKF Diagnostics
Legal namestring
EKF-diagnostic GmbH
Company typeenum
Public
Founded yearint
1990
Descriptiontext

EKF Diagnostics is a global in-vitro diagnostics manufacturer specializing in point-of-care (POC) blood analyzers. Founded in 1990 in Magdeburg, Saxony-Anhalt, and reorganized in 2011 under UK-listed EKF Diagnostics Holdings plc (London Stock Exchange), the company operates its manufacturing at EKF-diagnostic GmbH in Barleben, Germany, with regional subsidiaries in the USA (Newark), Russia (Moscow), and China (Beijing), and over 300 employees worldwide.

Its product portfolio centers on portable and benchtop analyzers for glucose, HbA1c, lactate, hemoglobin, and hematocrit across diabetology, hematology, sports medicine, veterinary medicine, and women's health. Core hardware includes the Biosen C-Line (glucose/lactate), Quo-Test and Quo-Lab (HbA1c in 4 minutes from 4 μL whole blood), DiaSpect Tm (reagent-free hemoglobin in ~1 second using white-LED optics), Hemo Control (azidmethemoglobin dry-reagent cuvettes with 570nm/880nm measurement), Hemo Vet (veterinary), Lactate Scout Sport, and Crematocrit Plus. The platform also encompasses PrimeStore MTM — a patented, FDA Class II-cleared, IVD CE-marked molecular transport medium that inactivates SARS-CoV-2, influenza, HIV, and TB while preserving DNA/RNA at room temperature for up to 7 days, and EKF Link as a connectivity module. Technical differentiators rest on chemistry (guanidinthiocyanat inactivation), reagent-free optical sensing, and dry-reagent cuvette architectures.

Revenue is generated through a combination of analyzer hardware sales and recurring consumables (cuvettes, reagents, PrimeStore MTM tubes with 24-month shelf life vs. <6 months for standard VTM/UTM), creating an annuity layer atop the installed base. Distribution is multi-channel: enterprise field sales, a network of 200+ dealers across 100+ countries, a strategic distribution agreement with Tosoh Europe N.V. for Middle East and Africa, and a direct-to-consumer e-commerce storefront (lactatescout.shop). A 14-day free-trial offering supports SMB practice acquisition. End customers span diabetes clinics, doctor's offices, hospitals, blood banks, sports performance centers, veterinary practices, and — for PrimeStore MTM — healthcare, education, and industrial COVID-19 testing programs.

Short descriptiontext

EKF Diagnostics is a Germany-headquartered manufacturer of point-of-care blood analyzers for glucose, HbA1c, lactate, hemoglobin, and hematocrit, serving diabetes clinics, hospitals, blood banks, sports medicine, and veterinary customers across 100+ countries under UK-listed EKF Diagnostics Holdings plc.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSaarlouis, Germany
HQ citystring
Saarlouis
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
point-of-care diagnostics, in-vitro diagnostics, HbA1c analyzers, molecular transport media, hematology analyzers
Industry3 codes
PRIMARYHLAAALAH
Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing)
SECONDARYHLAMADAA
Reference Laboratory Testing (Clinical Pathology & Chemistry)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYHLAHAOAI
Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code3 codes
  • Laboratory Analytical Instruments3826
  • In Vitro & In Vivo Diagnostic Substances2835
  • Surgical & Medical Instruments & Apparatus3841
Product category
In-Vitro Diagnostics / Point-of-Care Blood Analyzers
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1POC Diagnostic Analyzers
TypeHardware Sales
Description

Sale of point-of-care diagnostic devices including Biosen C-Line, Quo-Test, Quo-Lab, DiaSpect Tm, Hemo Control, and Lactate Scout Sport for measuring glucose, HbA1c, lactate, hemoglobin, and hematocrit parameters.

ekfdiagnostics.de
2Consumables and Reagents
TypeSubscription Recurring
Description

Recurring revenue from single-use cuvettes, reagents, and PrimeStore MTM tubes for molecular sample collection and transport. PrimeStore MTM has 24-month shelf life compared to less than 6 months for standard VTM/UTM.

ekfdiagnostics.de
3COVID-19 Testing Solutions
TypeHardware Sales
Description

PrimeStore MTM molecular transport medium for COVID-19 and influenza testing programs. Volume-driven sales to healthcare, education, and industrial sector customers.

ekfdiagnostics.de
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
114-day free trial available for POC devices in medical practices
ModelFreemiumBilling cadenceOne time/ perpetual license
Notes

EKF offers 14-day free trial for Point-of-Care devices in medical practices to demonstrate value before purchase commitment.

ekfdiagnostics.de
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

EKF Diagnostics manufactures and sells point-of-care (POC) blood diagnostic analyzers for measuring glucose, HbA1c, lactate, hemoglobin, and hematocrit across diabetology, hematology, sports medicine, veterinary medicine, and maternal care settings. Its product portfolio includes the Biosen C-Line, Quo-Test, Quo-Lab, DiaSpect Tm, Hemo Control, Hemo Vet, and Lactate Scout Sport analyzers, plus PrimeStore MTM, an FDA Class II cleared and IVD CE-marked molecular transport medium for safe inactivation and transport of infectious samples in molecular diagnostics. The offering is complemented by EKF Link connectivity software and a recurring consumables stream (cuvettes, reagents, MTM tubes).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • DiaSpect Tm delivers hemoglobin results in approximately 1 second
+5 more records
Product overview1 text field

EKF Diagnostics is a global in vitro diagnostics company specializing in point-of-care (POC) blood testing analyzers manufactured in Germany. The product portfolio centers on portable and benchtop analyzers for measuring glucose, HbA1c, lactate, hemoglobin, and hematocrit across diabetology, hematology, sports medicine, and veterinary applications. Key products include the Biosen C-Line for glucose/lactate, Quo-Test and Quo-Lab for HbA1c, DiaSpect Tm and Hemo Control for hemoglobin/hematocrit, and Lactate Scout Sport for lactate. The company also offers PrimeStore MTM, an FDA-approved molecular transport medium for safe sample inactivation and nucleic acid preservation in molecular diagnostics. EKF Link provides connectivity between analyzers and external systems. Over 80,000 analyzers are in regular use across more than 100 countries, with production based in Barleben, Germany.

Product and service2 records
1PrimeStore MTM (Molecular Transport Medium)
CategoryMolecular Transport Medium / Sample Collection
Description

FDA-approved Class II molecular transport medium that inactivates viruses (including SARS-CoV-2, influenza, HIV, TB), bacteria, fungi, and Mycobacterium tuberculosis while preserving DNA and RNA for molecular diagnostics, supporting qPCR and Next-Generation-Sequencing applications. Targeted at hospitals, diagnostic laboratories, public health agencies, and molecular diagnostics service providers.

2Biosen C-Line
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Tosoh Europe N.V.
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2020-01-01
Description

Three-year distribution agreement for Quo-Test HbA1c point-of-care analyzer covering Middle East and Africa markets. Tosoh Europe, one of the world's largest HPLC manufacturers, expands into POC HbA1c testing while EKF gains access to Tosoh's established laboratory customer base. Tosoh's analyzers are commonly used for comparison and validation of POC devices like Quo-Test. Agreement can be extended for additional one-year periods and potentially expanded to EU countries.

ekfdiagnostics.de
2Yourgene Health
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

International molecular diagnostics company using PrimeStore MTM for delivery of COVID-19 testing kits to schools, universities, and corporate clients. Dr. Sean Sales, Head of Genomic Services at Yourgene Health, stated: 'Safety was the main reason we chose PrimeStore MTM. The MTM inactivates the SARS-CoV-2 virus and stabilizes the RNA, enabling safe handling of incoming samples that could contain a Group 3 pathogen in a Class II MSW.' Yourgene invests in laboratory facilities to test tens of thousands of samples per month.

ekfdiagnostics.de
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

UK university using PrimeStore MTM for COVID-19 testing program for students as part of pandemic response measures.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

ISO:15189 certified laboratory testing services provider for UK NHS (National Health Service) and private healthcare sector. Using PrimeStore MTM for safe sample collection in COVID-19 testing programs.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

UK government health authority that published independent study validating PrimeStore MTM effectiveness for SARS-CoV-2 inactivation. Study tested 23 commercially available reagents and found PrimeStore MTM was the only reagent where no residual virus was detectable via TCID50 or blind passage. PHE validation provided scientific credibility for PrimeStore MTM's safety claims.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Siemens Healthineers offers the DCA Vantage HbA1c analyzer and the epoc blood gas system, directly competing with EKF's Quo-Test/Quo-Lab. As a much larger diversified IVD incumbent, Siemens bundles POC analyzers with central lab and imaging portfolios.

TypeDirect peer
Description

HemoCue (a Danaher subsidiary) is a direct competitor in point-of-care hemoglobin and glucose testing, with product lines that overlap EKF's DiaSpect Tm and Hemo Control analyzers across blood banks, clinics, and anemia screening programs.

TypeDirect peer
Description

Nova Biomedical manufactures POC glucose and lactate analyzers (StatStrip, Lactate Plus) with overlapping customer profiles in sports medicine, diabetes clinics, and hospitals—the same core use cases EKF serves with its Biosen C-Line and Lactate Scout Sport products.

4DiaSys Diagnostic Systems
TypeEmerging player
Description

DiaSys Diagnostic Systems manufactures clinical chemistry reagents and analyzers with overlapping diagnostic menu (glucose, HbA1c, lactate) for hospital and reference lab settings. While more reagent-focused than EKF, it overlaps in several of EKF's clinical chemistry POC use cases.

5Abbott Point of Care
TypeBroad incumbent
Description

Abbott's i-STAT system and Piccolo Xpress analyzers compete with EKF's POC portfolio across hospital point-of-care settings. Abbott is a broad IVD incumbent with significantly greater resources, hospital relationships, and menu breadth than EKF.

TypeBroad incumbent
Description

Bio-Rad manufactures the Variant II and D-10 HPLC systems for HbA1c testing, which compete with EKF's POC HbA1c analyzers at the laboratory and clinic interface. As an established clinical diagnostics player, Bio-Rad brings broader menus and reference lab relationships.

TypeDirect peer
Description

Trinity Biotech specializes in HbA1c and clinical chemistry diagnostics including POC platforms (formerly PTS Diagnostics). It directly competes with EKF's Quo-Test/Quo-Lab in diabetes management settings, particularly in the US market.

TypeBroad incumbent
Description

Roche's cobas b101 POC HbA1c analyzer and Accu-Chek glucose meters compete directly with EKF's Quo-Test and glucose offerings. As the largest global IVD player, Roche has substantial R&D scale, distribution, and bundling power that EKF must compete against.

TypeEmerging player
Description

Erba Mannheim produces clinical chemistry analyzers and reagents (e.g., XL series) with comparable menu coverage to EKF's clinical chemistry offerings. Operating from Germany and serving emerging markets, Erba is a smaller but adjacent competitor in IVD chemistry and hematology niches.

TypeBroad incumbent
Description

Radiometer, owned by Danaher, sells blood gas and immunoassay POC analyzers (ABL, AQT) used in hospital near-patient settings. It competes with EKF's broader POC analyzer portfolio in clinical chemistry and hematology at the point of care.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EKF Diagnostics

In-Vitro Diagnostics / Point-of-Care Blood Analyzersekfdiagnostics.de

EKF Diagnostics is a Germany-headquartered manufacturer of point-of-care blood analyzers for glucose, HbA1c, lactate, hemoglobin, and hematocrit, serving diabetes clinics, hospitals, blood banks, sports medicine, and veterinary customers across 100+ countries under UK-listed EKF Diagnostics Holdings plc.

What EKF Diagnostics does

EKF Diagnostics is a global in-vitro diagnostics manufacturer specializing in point-of-care (POC) blood analyzers. Founded in 1990 in Magdeburg, Saxony-Anhalt, and reorganized in 2011 under UK-listed EKF Diagnostics Holdings plc (London Stock Exchange), the company operates its manufacturing at EKF-diagnostic GmbH in Barleben, Germany, with regional subsidiaries in the USA (Newark), Russia (Moscow), and China (Beijing), and over 300 employees worldwide.

Its product portfolio centers on portable and benchtop analyzers for glucose, HbA1c, lactate, hemoglobin, and hematocrit across diabetology, hematology, sports medicine, veterinary medicine, and women's health. Core hardware includes the Biosen C-Line (glucose/lactate), Quo-Test and Quo-Lab (HbA1c in 4 minutes from 4 μL whole blood), DiaSpect Tm (reagent-free hemoglobin in ~1 second using white-LED optics), Hemo Control (azidmethemoglobin dry-reagent cuvettes with 570nm/880nm measurement), Hemo Vet (veterinary), Lactate Scout Sport, and Crematocrit Plus. The platform also encompasses PrimeStore MTM — a patented, FDA Class II-cleared, IVD CE-marked molecular transport medium that inactivates SARS-CoV-2, influenza, HIV, and TB while preserving DNA/RNA at room temperature for up to 7 days, and EKF Link as a connectivity module. Technical differentiators rest on chemistry (guanidinthiocyanat inactivation), reagent-free optical sensing, and dry-reagent cuvette architectures.

Revenue is generated through a combination of analyzer hardware sales and recurring consumables (cuvettes, reagents, PrimeStore MTM tubes with 24-month shelf life vs. <6 months for standard VTM/UTM), creating an annuity layer atop the installed base. Distribution is multi-channel: enterprise field sales, a network of 200+ dealers across 100+ countries, a strategic distribution agreement with Tosoh Europe N.V. for Middle East and Africa, and a direct-to-consumer e-commerce storefront (lactatescout.shop). A 14-day free-trial offering supports SMB practice acquisition. End customers span diabetes clinics, doctor's offices, hospitals, blood banks, sports performance centers, veterinary practices, and — for PrimeStore MTM — healthcare, education, and industrial COVID-19 testing programs.

EKF Diagnostics firmographics

Firmographics
Name
EKF Diagnostics
Legal name
EKF-diagnostic GmbH
Website
https://ekfdiagnostics.de
Company type
Public
Founded year
1990
Operating status
Operating
Headcount range
51–100 employees
Short description
EKF Diagnostics is a Germany-headquartered manufacturer of point-of-care blood analyzers for glucose, HbA1c, lactate, hemoglobin, and hematocrit, serving diabetes clinics, hospitals, blood banks, sports medicine, and veterinary customers across 100+ countries under UK-listed EKF Diagnostics Holdings plc.
Ownership category
akta.pro rank

EKF Diagnostics industry classification

Industry
Product category
In-Vitro Diagnostics / Point-of-Care Blood Analyzers
NAICS
Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAAALAH
Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing)
SECONDARYHLAMADAA
Reference Laboratory Testing (Clinical Pathology & Chemistry)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYHLAHAOAI
Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics

Keywords

  • Point-of-care diagnostics
  • In-vitro diagnostics
  • HbA1c analyzers
  • Molecular transport media
  • Hematology analyzers

Where EKF Diagnostics is headquartered

Location

Headquarters

HQ city
Saarlouis
HQ country
Germany
HQ region
Europe

Offices5 records

Markets served

EKF Diagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. POC Diagnostic Analyzers: Sale of point-of-care diagnostic devices including Biosen C-Line, Quo-Test, Quo-Lab, DiaSpect Tm, Hemo Control, and Lactate Scout Sport for measuring glucose, HbA1c, lactate, hemoglobin, and hematocrit parameters.
  2. Consumables and Reagents: Recurring revenue from single-use cuvettes, reagents, and PrimeStore MTM tubes for molecular sample collection and transport. PrimeStore MTM has 24-month shelf life compared to less than 6 months for standard VTM/UTM.
  3. COVID-19 Testing Solutions: PrimeStore MTM molecular transport medium for COVID-19 and influenza testing programs. Volume-driven sales to healthcare, education, and industrial sector customers.

Pricing tiers

ModelBillingPrice
FreemiumOne time/ perpetual license14-day free trial available for POC devices in medical practices

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

EKF Diagnostics product offering

Product offering

Core offering

EKF Diagnostics manufactures and sells point-of-care (POC) blood diagnostic analyzers for measuring glucose, HbA1c, lactate, hemoglobin, and hematocrit across diabetology, hematology, sports medicine, veterinary medicine, and maternal care settings. Its product portfolio includes the Biosen C-Line, Quo-Test, Quo-Lab, DiaSpect Tm, Hemo Control, Hemo Vet, and Lactate Scout Sport analyzers, plus PrimeStore MTM, an FDA Class II cleared and IVD CE-marked molecular transport medium for safe inactivation and transport of infectious samples in molecular diagnostics. The offering is complemented by EKF Link connectivity software and a recurring consumables stream (cuvettes, reagents, MTM tubes).

Product overview

EKF Diagnostics is a global in vitro diagnostics company specializing in point-of-care (POC) blood testing analyzers manufactured in Germany. The product portfolio centers on portable and benchtop analyzers for measuring glucose, HbA1c, lactate, hemoglobin, and hematocrit across diabetology, hematology, sports medicine, and veterinary applications. Key products include the Biosen C-Line for glucose/lactate, Quo-Test and Quo-Lab for HbA1c, DiaSpect Tm and Hemo Control for hemoglobin/hematocrit, and Lactate Scout Sport for lactate. The company also offers PrimeStore MTM, an FDA-approved molecular transport medium for safe sample inactivation and nucleic acid preservation in molecular diagnostics. EKF Link provides connectivity between analyzers and external systems. Over 80,000 analyzers are in regular use across more than 100 countries, with production based in Barleben, Germany.

Differentiator

Problem solved

Functional benefit

Products and services

  • PrimeStore MTM (Molecular Transport Medium) FDA-approved Class II molecular transport medium that inactivates viruses (including SARS-CoV-2, influenza, HIV, TB), bacteria, fungi, and Mycobacterium tuberculosis while preserving DNA and RNA for molecular diagnostics, supporting qPCR and Next-Generation-Sequencing applications. Targeted at hospitals, diagnostic laboratories, public health agencies, and molecular diagnostics service providers.
  • Biosen C-Line

Quantifiable outcome

  • DiaSpect Tm delivers hemoglobin results in approximately 1 second
  • +5 more outcomes

Companies that use EKF Diagnostics

Customer profile

Named customers4 records

Segments6 records

Ideal customer profiles6 records

EKF Diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

EKF Diagnostics partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Tosoh Europe N.V.coreChannel Partner/ Reseller/ Distributor · 1 January 2020Three-year distribution agreement for Quo-Test HbA1c point-of-care analyzer covering Middle East and Africa markets. Tosoh Europe, one of the world's largest HPLC manufacturers, expands into POC HbA1c testing while EKF gains access to Tosoh's established laboratory customer base. Tosoh's analyzers are commonly used for comparison and validation of POC devices like Quo-Test. Agreement can be extended for additional one-year periods and potentially expanded to EU countries.
  • Yourgene HealthcoreStrategic or Co-development Partner · 1 January 2020International molecular diagnostics company using PrimeStore MTM for delivery of COVID-19 testing kits to schools, universities, and corporate clients. Dr. Sean Sales, Head of Genomic Services at Yourgene Health, stated: 'Safety was the main reason we chose PrimeStore MTM. The MTM inactivates the SARS-CoV-2 virus and stabilizes the RNA, enabling safe handling of incoming samples that could contain a Group 3 pathogen in a Class II MSW.' Yourgene invests in laboratory facilities to test tens of thousands of samples per month.
  • University of LeicesterminorStrategic or Co-development Partner · 1 January 2020UK university using PrimeStore MTM for COVID-19 testing program for students as part of pandemic response measures.
  • Source BioScienceminorStrategic or Co-development Partner · 1 January 2020ISO:15189 certified laboratory testing services provider for UK NHS (National Health Service) and private healthcare sector. Using PrimeStore MTM for safe sample collection in COVID-19 testing programs.
  • Public Health England (PHE)coreStrategic or Co-development Partner · 1 January 2020UK government health authority that published independent study validating PrimeStore MTM effectiveness for SARS-CoV-2 inactivation. Study tested 23 commercially available reagents and found PrimeStore MTM was the only reagent where no residual virus was detectable via TCID50 or blind passage. PHE validation provided scientific credibility for PrimeStore MTM's safety claims.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

EKF Diagnostics competitors and assessment

Company assessment

Broad incumbents

  • Siemens Healthineers: Siemens Healthineers offers the DCA Vantage HbA1c analyzer and the epoc blood gas system, directly competing with EKF's Quo-Test/Quo-Lab. As a much larger diversified IVD incumbent, Siemens bundles POC analyzers with central lab and imaging portfolios.
  • Abbott Point of Care: Abbott's i-STAT system and Piccolo Xpress analyzers compete with EKF's POC portfolio across hospital point-of-care settings. Abbott is a broad IVD incumbent with significantly greater resources, hospital relationships, and menu breadth than EKF.
  • Bio-Rad Laboratories: Bio-Rad manufactures the Variant II and D-10 HPLC systems for HbA1c testing, which compete with EKF's POC HbA1c analyzers at the laboratory and clinic interface. As an established clinical diagnostics player, Bio-Rad brings broader menus and reference lab relationships.
  • Roche Diagnostics: Roche's cobas b101 POC HbA1c analyzer and Accu-Chek glucose meters compete directly with EKF's Quo-Test and glucose offerings. As the largest global IVD player, Roche has substantial R&D scale, distribution, and bundling power that EKF must compete against.
  • Radiometer (Danaher): Radiometer, owned by Danaher, sells blood gas and immunoassay POC analyzers (ABL, AQT) used in hospital near-patient settings. It competes with EKF's broader POC analyzer portfolio in clinical chemistry and hematology at the point of care.

Direct peers

  • HemoCue: HemoCue (a Danaher subsidiary) is a direct competitor in point-of-care hemoglobin and glucose testing, with product lines that overlap EKF's DiaSpect Tm and Hemo Control analyzers across blood banks, clinics, and anemia screening programs.
  • Nova Biomedical: Nova Biomedical manufactures POC glucose and lactate analyzers (StatStrip, Lactate Plus) with overlapping customer profiles in sports medicine, diabetes clinics, and hospitals—the same core use cases EKF serves with its Biosen C-Line and Lactate Scout Sport products.
  • Trinity Biotech: Trinity Biotech specializes in HbA1c and clinical chemistry diagnostics including POC platforms (formerly PTS Diagnostics). It directly competes with EKF's Quo-Test/Quo-Lab in diabetes management settings, particularly in the US market.

Emerging players

  • DiaSys Diagnostic Systems: DiaSys Diagnostic Systems manufactures clinical chemistry reagents and analyzers with overlapping diagnostic menu (glucose, HbA1c, lactate) for hospital and reference lab settings. While more reagent-focused than EKF, it overlaps in several of EKF's clinical chemistry POC use cases.
  • Erba Mannheim: Erba Mannheim produces clinical chemistry analyzers and reagents (e.g., XL series) with comparable menu coverage to EKF's clinical chemistry offerings. Operating from Germany and serving emerging markets, Erba is a smaller but adjacent competitor in IVD chemistry and hematology niches.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

EKF Diagnostics social profiles

Digital presence

EKF Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EKF Diagnostics leadership team

Management profile

Number of profiles

Profiles5 records

EKF Diagnostics subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

EKF Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EKF Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EKF Diagnostics

What does EKF Diagnostics do?

EKF Diagnostics manufactures and sells point-of-care (POC) blood diagnostic analyzers for measuring glucose, HbA1c, lactate, hemoglobin, and hematocrit across diabetology, hematology, sports medicine, veterinary medicine, and maternal care settings. Its product portfolio includes the Biosen C-Line, Quo-Test, Quo-Lab, DiaSpect Tm, Hemo Control, Hemo Vet, and Lactate Scout Sport analyzers, plus PrimeStore MTM, an FDA Class II cleared and IVD CE-marked molecular transport medium for safe inactivation and transport of infectious samples in molecular diagnostics. The offering is complemented by EKF Link connectivity software and a recurring consumables stream (cuvettes, reagents, MTM tubes).

Is EKF Diagnostics a public or private company?

EKF Diagnostics is a public company. It is classified as public and is currently operating.

When was EKF Diagnostics founded?

EKF Diagnostics was founded in 1990. It employs 51 to 100 people.

Where is EKF Diagnostics based?

EKF Diagnostics is headquartered in Saarlouis, Germany, in the Europe region.

How does EKF Diagnostics make money?

Three revenue lines are on record. POC Diagnostic Analyzers are the primary driver. The others are consumables and Reagents and COVID-19 Testing Solutions.

Who are EKF Diagnostics's main competitors?

Broad incumbents on record are Siemens Healthineers, Abbott Point of Care, Bio-Rad Laboratories, Roche Diagnostics and Radiometer (Danaher). Direct peers are HemoCue, Nova Biomedical and Trinity Biotech. Emerging players are DiaSys Diagnostic Systems and Erba Mannheim.

Does EKF Diagnostics have an API?

No public API is recorded for EKF Diagnostics.

What industry is EKF Diagnostics in?

EKF Diagnostics's product category is In-Vitro Diagnostics / Point-of-Care Blood Analyzers. Its primary akta.pro industry code is HLAAALAH, Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing), with a secondary code of HLAMADAA, Reference Laboratory Testing (Clinical Pathology & Chemistry). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals